AzTrials
AzTrials

Shared Decision MakingNCT05091944

An Interactive Web-based Birth Decision Aid for Shared Decision Making

A study testing web-based birth decision aid in people with Shared Decision Making and Vaginal Birth After Cesarean, run by National Taipei University of Nursing and Health Sciences at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

An interactive web-based decision aid for shared decision making: birth choice after cesarean in Taiwan Background: Taiwan has a high national caesarean rate coupled with a low vaginal birth after caesarean (VBAC) rate. Read more about this study

Who is it for?
Ages 20 to 45 years, women only
What is being tested?
web-based birth decision aid
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
1 siteTaiwan
Study dates
15 Sep 2021to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • pregnant women had experienced one previous cesarean
  • pregnant women had at least a half year interval between current pregnancy and the previous birth

Who cannot join

  • women are multiple pregnancy
  • women had previous classic CS or myomectomy
  • pregnant women have high risk of complications

Trial locations and contacts

1 site in 1 country.

Chang-Ching Yeh, PhD contact

886-2-28757826

ccyeh39@gmail.com

Taiwan1 site, 1 recruiting
  • Taipei Veterans General Hospital

    Taipei, 11217

    Shu Wen Chen, PhD, 886-2-28227101 ext. 3123, shuwen@ntunhs.edu.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: An Interactive Web-based Decision Aid for Shared Decision Making: Birth Choice After Cesarean in Taiwan

An interactive web-based decision aid for shared decision making: birth choice after cesarean in Taiwan

Background: Taiwan has a high national caesarean rate coupled with a low vaginal birth after caesarean (VBAC) rate. Studies suggest that pregnant women do not receive sufficient information about birth choices after caesarean in Taiwan and shared decision making (SDM) is not an expectation. Chen conducted a pilot study. Improvements in knowledge for the decision aid group were larger than for the usual care group, although differences between groups were not statistically significant. An interactive multimedia technology and humanity communication may provide opportunities to increase engagement and support women during decision consultations. Following previous pilot study, the study aims to examine the effectiveness of an interactive web-based birth decision aid for SDM in pregnant women who have had a previous cesarean.

Read more

Methods: A quantitative approach will be conducted with a randomized pre-test and post-test experimental design in a medical center in northern Taiwan. Participants who have had one previous CS will be recruited at 14-16 weeks. A total of 172 women will be completed a baseline survey and will be randomly allocated to either the intervention (usual care plus an interactive web-based birth decision aid ) or usual care (general maternal health booklet) group. A follow up survey at 35-38 weeks measured change in decisional conflict, knowledge, birth preference and decision aid acceptability. Actual birth outcomes and satisfaction will be assessed one month after birth.

Contributions/ Implementation of clinical practice The study will potentially increase women and obstetricians to support VBAC and SDM. The interactive decision aid tool may reduce time-consumption for health education. Linking web-based data analysis of AI into medical record can be beneficial for clinical practice and research in the future.

Read the detailed description

Study design:

A sequential mixed methods approach was conducted based on the Ottawa Decision Support Framework (ODSF). The current study will represent Aim 4 (Intervention implementation phase), comprising two stages. Stage 1 involves a randomized pre-test and post-test experimental design. Decisional conflict, knowledge, birth preference, and decision aid acceptability are assessed. Stage 2 consists of a survey, actual birth outcome and satisfaction are assessed.

Setting and participants:

The study will be conducted in a medical center in northern Taiwan. The medical center offers 24-hour system of the designated obstetrician. Using purposive sampling, the selection criteria include women who are medically eligible for VBAC in the study site, had experienced one previous CS, 14-16 weeks' gestation, had at least a half year interval between current pregnancy and the previous birth and are fluent in English or Mandarin. Exclusion criteria included women with multiple pregnancy, previous classic CS or myomectomy, and/or pregnancy with high risk of complications (for example, women who had risk factors such as hypertension, heart disease, diabetes, epilepsy, threatened premature labor, or another pre-existing medical problem).

Randomization:

Prior to the study commencing, the research team will conduct online discussions to clarify the research protocol. Eligible participants will be provided information about the study by the principal researcher and signed a written consent. Using computer permuted block randomization, participants will be allocated to control group (usual care) and intervention group (usual care plus the interactive web-based birth decision aid). After administering the baseline questionnaire, women will be allocated to the intervention group and give instructions by the principal researcher on how to log in the interactive birth decision aid platform/App. All participants confirm preferred mode of birth with their obstetrician prior to completing the second questionnaire.

Usual care:

A maternal health booklet, produced by Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan, will be provided to all women. The booklet consists of 58 pages, presenting 5 "Dos" and 5 "Don'ts" during pregnancy. 5 "Dos" content included (1) Do receive prenatal exams according to schedule; (2) Do take good care during pregnancy; (3) Do recognize pregnancy complications; (4) Do know the signs of premature birth; (5) Do know the signs of labor. 5 "Don'ts" content included (1) Do not smoke or drink; (2) Do not be exposed to secondhand smoke; (3) Do not take medication without doctor's orders; (4) Do not choose a C-section in order to pick the time of birth; (5) Do not use drugs (52). There is very limited information relevant to mode of birth choice after caesarean.

Intervention:

Women in the intervention group will receive both usual care and decision support (an interactive web-based birth decision aid ). The interactive web-based birth decision aid will be modified from Professor Allison Shorten (English audio). We add communication aid at the beginning of platform/App. The communication aid comprises two components: components 1-how to participate in SDM and apply three talk to work together with clinicians (10 minutes) ; component 2-practice communication skill (10 minutes). Women will be assisted to create a unique username and password for secure decision aid access and its features and functions will be demonstrated. Intervention women will be invited to access the decision aid at home. All women are allowed to have many opportunities to access and use the decision aid during their pregnancy and will be recorded. They are encouraged to use the decision aid during recruitment and gestation visit in the Outpatient Department of Obstetrics. The principal researcher will provide 2-3 online consultations for individual women.

Outcome measures :

There are three primary and two secondary outcome measures. Primary outcome measures are decisional conflict, knowledge, birth preference and decision aid acceptability. Decisional conflict score (DCS)includes 16 questions in 5 sub-scale. Using the 5-point Likert 5 rating, from "strongly agree" ( 0 points) to "strongly disagree" (4 points). Knowledge measurement consists of a 15-item questionnaire asking participants to answer ''true,'' ''false,'' or ''unsure'' to a series of statements regarding risks and benefits of each birth mode. Previously tested Cronbach α for this questionnaire was = 0.67.

Secondary outcome measures are actual birth outcome and satisfaction. Satisfaction with decision scale (SWD) included six questions to measure women's satisfaction with their decision, using the Likert 5 rating, from "strongly agree" (5 points) to "strongly disagree" (1 points). Women have higher scores indicating increased SWD. Cronbach's α previously tested was 0.88.

Sample size :

Using G-POWER 3.1.9.2 software, sample size was calculated. Based on estimates from a previous pilot study, effect size=.40, a total of sample size 156 provides α = .05 and power = .80. To allow for preterm deliveries, mal-presentations, and losses to follow-up, an increase in the desired number by 10 percent would be 172.

Data collection and procedures :

Eligible women will be invited to participate in the study when they attend prenatal examination at the 14-16 weeks' gestation visit in the Outpatient Department of Obstetrics and Gynecology. After participants sign written consent for participation, women will be allocated to either the intervention group or control group. All participants will complete "personal basic information", "decision conflict scale" and "knowledge scale" in a quiet room. After completion of questionnaires, an interactive birth decision aid platform/App will be provided for intervention group women to discuss with their families at home. Individual consultations will be provided for intervention group women, by the principal researcher, at least twice during the 17-34 weeks' gestation period. All participants will complete "decision conflict scale" and "knowledge scale" and "decision aid acceptability at 35-38 weeks' gestation. A follow-up is held one month after birth. Postnatal women will be asked about "actual birth outcomes '' and complete a "satisfaction" questionnaire when they attend their postnatal examination visit .

Data analysis:

Quantitative data is managed and analyze using IBM SPSS Version 26.0. In terms of DCS and knowledge scores, matched pairs t-tests are used to compare differences between groups in change between pre and post test scores.

Being tested
web-based birth decision aid
Keywords
communication aids, web-based decision aids

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • web-based birth decision aidDevice

    Women in the intervention group receive both usual care and decision support (an interactive web-based birth decision aid). The innovative interactive web-based birth decision aid comprised five components: Component 1-a communication aid video involves 2 expert's talk about how to participate in SDM and prepare self with choice talk, option talk and decision talk(10 minutes )and practice communication skills with clinician(10 minutes); Component 2-overall of the function and features of birth decision aid. Component 3-introduce the benefits and risk of vaginal birth after cesarean; Component 4- the benefits and risk of elective repeat cesarean section; Component 5 -a quit to confirm women's knowledge regarding the two choices and confirm women's values.

Study groups in NCT05091944
Study groupRoleWhat they receive
interventionExperimentalusual care plus web-based birth decision aid
Receives: Device: web-based birth decision aid
controlNo interventionususal care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change is being assessed-decisional conflict

    Decisional conflict score (DCS)includes 16 questions. Using the 5-point Likert 5 rating, from "strongly agree" (0 points) to "strongly disagree" (4 points)

    Measured: 14-16 week gestation and 35-38week gestation

  2. change is being assessed-knowledge

    Knowledge measurement consists of a 15-item questionnaire asking participants to answer ''true,'' ''false,'' or ''unsure'' to a series of statements regarding risks and benefits of each birth mode

    Measured: 14-16 week gestation and 35-38week gestation

  3. change is being assessed-birth preference

    VBAC/ERCS

    Measured: 14-16 week gestation and 35-38week gestation

  4. decision aid acceptability

    Decision aid acceptability included nine questions to measure women's acceptability regarding decision aid , using the Likert 5 rating, from "not at all" (1 points) to "a great deal" (5 points)

    Measured: 35-38week gestation

Secondary outcomes (2)
  1. Actual birth outcomes

    VBAC or ERCS

    Measured: one month after birth

  2. satisfaction of decision

    Satisfaction with decision scale (SWD) included six questions to measure women's satisfaction with their decision, using the Likert 5 rating, from "strongly agree" (5 points) to "strongly disagree" (1 points).

    Measured: one month after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2021
  2. Study start15 Sep 2021
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05091944
Sponsor's protocol ID
2021-02-003A
Status last verified
Oct 2021
First submitted
14 Sep 2021
Last updated
29 Oct 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chen SW, Shorten A, Yeh CC, Kao CH, Lu YY, Hu HW. An innovative web-based decision-aid about birth after cesarean for shared decision making in Taiwan: study protocol for a randomized control trial. Trials. 2023 Feb 9;24(1):103. doi: 10.1186/s13063-023-07103-8.

    PubMed 36759893

Questions about this trial

What is this clinical trial studying?

A study testing web-based birth decision aid in people with Shared Decision Making and Vaginal Birth After Cesarean, run by National Taipei University of Nursing and Health Sciences at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shu Wen Chen, PhD (886-2-28227101 ext. 3123, shuwen@ntunhs.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change is being assessed-decisional conflict (time frame: 14-16 week gestation and 35-38week gestation). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05091944, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in